Loading...
01/10 19:42
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights several challenges: a 3% revenue decline, increased SG&A expenses leading to a net loss, and liquidity concerns with only $2.3 million in cash. The box office underperformance and competitive pressures in technology and micro drama ventures add to the negative sentiment. Despite some positives like streaming growth and improved margins, the overall outlook is clouded by financial and strategic uncertainties, leading to a likely negative stock price reaction.
Total Revenue $12.7 million, down 3% year-over-year. The decline was attributed to timing effects of licensing deals, such as a $1.1 million licensing deal for The Toxic Avenger that will be recognized in future periods.
Operating Margins Grew by 7% year-over-year to 58%. This improvement was due to cost control measures and leveraging efficiencies from Cineverse Services India to manage SG&A spending.
Net Loss $5.5 million compared to $1.2 million in the prior year quarter. The increase in net loss was primarily due to higher SG&A expenses driven by investments in sales, marketing, and technology, as well as start-up costs for the MicroCo venture.
Adjusted EBITDA Negative $3.7 million compared to $0.5 million in the prior year quarter. The decline was attributed to the same factors affecting net loss, including increased SG&A expenses and investments in new initiatives.
Cash and Cash Equivalents $2.3 million as of September 30, 2025, with $5.9 million available on a $12.5 million working capital facility. The decline in cash was due to royalty payments and advance payments for the theatrical slate.
Content Library Valuation Valued at $45 million, significantly higher than the $3.2 million book value. This increase reflects the material asset value not included on the balance sheet.
Streaming Viewers 143.8 million, up 47% year-over-year. This growth was driven by the success of key channels like Barney, Dog Whisperer, and Screambox TV.
Total Minutes Streamed 3.4 billion, up 45% year-over-year. FAST minutes streamed accounted for 3.2 billion of this total, up 47%.
SVOD Subscribers 1.39 million, a 6% increase year-over-year. Growth was supported by the launch of Terrifier 3 and other content initiatives.
The Toxic Avenger Unrated: Released on August 29, did not perform well at the box office but is performing well in ancillary distribution markets like VOD, physical, and licensing with Amazon and Hulu. Expected IRR of 40%.
Terrifier 3: Opened at #1 at the box office with $54 million in ticket sales on a $500,000 marketing spend. Demonstrates the success of Cineverse's low-cost, fan-centric film strategy.
Silent Night, Deadly Night and Return to Silent Hill: Upcoming releases with all-in investments projected to be below $5 million each, following the same low-cost, fan-centric strategy.
Air Bud Returns: Nearing completion of principal photography, generating buzz on social media and expected to release in late 2026.
Pan's Labyrinth 20th Anniversary Edition: Cineverse secured a multiyear domestic distribution deal for this classic film, with a marketing campaign starting in May 2026 for a late 2026 release.
Streaming Viewership: Total streaming viewers reached 143.8 million, up 47% year-over-year. Total minutes streamed were 3.4 billion, up 45%.
SVOD Subscribers: Grew to 1.39 million, a 6% increase year-over-year.
Matchpoint Technology: Added more than 20 new customers in the last 100 days, launched Matchpoint 3.0, and expanded internationally. Secured new partners and is under evaluation by major Hollywood studios.
MicroCo Venture: Aimed at becoming a leader in the $8 billion micro drama market. Received funding commitment from a leading venture capital firm and is actively engaging with additional partners.
Cost Management: Focused on controlling costs and leveraging Cineverse Services India to manage SG&A spending.
Content Library Valuation: Updated valuation of $45 million, significantly above the $3.2 million book value.
Advertising Strategy: Preparing for political spending and easing interest rates to boost ad business. Integrating AI-driven metadata repository into ad stack for better audience targeting.
Film Releasing Strategy: Low-cost, fan-centric approach to film releasing, attracting quality directors and producers.
Matchpoint Expansion: Positioning Matchpoint as the operating system for content libraries worldwide through strategic partnerships and acquisitions.
MicroCo Development: Building a platform for micro dramas with a leadership team of industry veterans and AI-native workflows.
Revenue Decline: Total revenues for the quarter were $12.7 million, down 3% from the prior year quarter. This decline, despite some licensing deals, indicates potential challenges in maintaining consistent revenue growth.
Box Office Performance: The Toxic Avenger Unrated did not perform as well as expected at the box office, which could indicate risks in the company's film portfolio strategy and reliance on theatrical releases.
SG&A Expenses: Increased SG&A expenses due to investments in sales, marketing, and technology have led to a net loss of $5.5 million and negative adjusted EBITDA of $3.7 million for the quarter. This raises concerns about the financial impact of these upfront investments.
Advertising Market Conditions: The advertising environment faced pressure due to macroeconomic concerns, tariff uncertainty, and increased inventory from competitors like Amazon and Netflix. This created choppiness in the category, impacting revenue.
Cash Flow and Liquidity: The company had $2.3 million in cash and cash equivalents as of September 30, with a decline in cash attributed to royalty payments and advance payments for theatrical releases. This could pose liquidity challenges if cash flow does not improve.
Dependence on Licensing Deals: Revenue recognition is heavily influenced by licensing deals, such as the $1.1 million deal for The Toxic Avenger Unrated. This dependency could lead to revenue volatility.
Competitive Pressures in Technology: Matchpoint technology faces a long and complex deal cycle, and while it has potential, the competitive landscape and reliance on large deals could pose risks to its growth trajectory.
Micro Drama Venture Risks: The newly formed MicroCo venture involves significant start-up costs and is entering a fragmented and competitive market. Success is uncertain, and the venture could strain resources if it does not perform as expected.
Revenue Growth: The company expects strong top and bottom-line results for the remainder of fiscal year 2026 and fiscal year 2027, driven by upfront investments in sales, marketing, and technology.
Film Releases: Upcoming releases include 'Silent Night, Deadly Night' on December 12, 2025, and 'Return to Silent Hill' on January 23, 2026. Both films are expected to follow a low-cost, high-return model with investments below $5 million each.
Future Film Projects: The family film 'Air Bud Returns' is expected to release in late calendar 2026. Additionally, the 20th anniversary edition of 'Pan's Labyrinth' is planned for a late 2026 theatrical release.
Content Library Valuation: The company's content library is valued at $45 million, significantly higher than its book value of $3.2 million, indicating potential for future monetization.
Streaming Growth: Streaming viewers increased by 47% year-over-year, with SVOD subscribers growing by 6%. The company anticipates continued growth in streaming metrics.
Advertising Revenue: Political spending and easing interest rates are expected to lift advertising revenue in fiscal Q4 and early fiscal Q1.
Matchpoint Technology: The Matchpoint platform added over 20 new customers in the last 100 days and is under evaluation by major Hollywood studios, indicating potential for significant recurring revenue.
MicroCo Venture: The MicroCo joint venture aims to become a leader in the $8 billion micro drama market, with significant commitments from venture firms and plans for AI-native platform development.
The selected topic was not discussed during the call.
The earnings call highlights several challenges: a 3% revenue decline, increased SG&A expenses leading to a net loss, and liquidity concerns with only $2.3 million in cash. The box office underperformance and competitive pressures in technology and micro drama ventures add to the negative sentiment. Despite some positives like streaming growth and improved margins, the overall outlook is clouded by financial and strategic uncertainties, leading to a likely negative stock price reaction.
The earnings call reveals financial challenges, including a net loss and cash flow concerns, despite revenue growth. The company's investments in new ventures and initiatives like MicroCo carry significant uncertainty and risk. The Q&A highlighted management's lack of clarity on key strategic initiatives, which may raise investor concerns. While there are positive aspects, such as streaming growth and direct advertising success, the overall sentiment leans negative due to financial strain and uncertainty around new ventures.
The earnings call summary reveals strong financial performance, with significant revenue growth and improved margins. The company is expanding into new content areas and has a promising pipeline for cineSearch and Matchpoint. However, some uncertainties remain, such as regulatory challenges and operational transitions. The Q&A section indicates management's confidence in margin targets and growth potential, despite avoiding specific timelines. Overall, the positive financial results and strategic initiatives outweigh the risks, suggesting a positive stock price movement.
Cineverse's earnings call revealed strong financial performance, with a 207% revenue increase and zero debt, indicating financial stability. The partnership with Google and AI integration are strategic positives, while cost-cutting measures enhance profitability. Despite vague responses in the Q&A, the company's optimistic guidance and strong revenue growth suggest a positive stock reaction. The lack of market cap data implies a neutral impact from size-related volatility. Overall, factors like strong earnings, strategic partnerships, and optimistic guidance outweigh any concerns, leading to a 'Positive' sentiment rating.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
